Amyotrophic lateral sclerosis and prolactinoma

From: Functional Neurology | Date: January 1, 2007| Author: Alevizaki, Maria; Gkiatas, Konstantinos; Markou, Ioannis; Stamboulis, Elevtherios; Kararizou, Evangelia | Copyright information

Summary

A 59-year-old male with amyotrophic lateral sclerosis is presented. Investigations revealed the co-existence of a pituitary adenoma of the prolactinoma type. This combination has not been reported before. The possible relation between endocrinological disturbances and this neurological disease is discussed.

KEY WORDS: ALS, amyotrophic lateral sclerosis, prolactinoma, prolactin

Introduction

Different endocrine disorders have been reported in association with...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and journal articles from HighBeam Research

Amyotrophic lateral sclerosis and prolactinoma
Functional Neurology ; Summary A 59-year-old male with amyotrophic lateral sclerosis is presented. Investigations revealed the co-existence of a pituitary adenoma of the prolactinoma type. This combination has not been reported before. The possible relation between endocrinological disturbances and this neurological
Amyotrophic Lateral Sclerosis: Current Understanding.
Journal of Neuroscience Nursing ; It was the eminent French neurologist Charcot who first described motor neuron disease (MND) in 1874 (Swash, 2000). Since his thorough and valid description, MND, or amyotrophic lateral sclerosis (ALS) as he termed it, remains an enigma (Mitsumoto, 1994). It is a degenerative disorder of the upper
Physical Therapy for a Patient Through Six Stages of Amyotrophic Lateral Sclerosis.
Physical Therapy ; Amyotrophic lateral sclerosis (ALS) is the most common motoneuron disease among adults.[1] The incidence of ALS is 0.4 to 2.4 cases per 100,000 people worldwide, with a prevalence of 2.5 to 7 cases per 100,000 people.[1-3] Amyotrophic lateral sclerosis is slightly more common in men than in women,
Amyotrophic Lateral Sclerosis: Lou Gehrig's Disease.
American Family Physician ; Amyotrophic lateral sclerosis (ALS), commonly called Lou Gehrig's disease, is a progressive neuromuscular condition characterized by weakness, muscle wasting, fasciculations and increased reflexes. Approximately 30,000 Americans currently have the disease. The annual incidence rate is one to two
Pharmacotherapeutic options in the treatment of amyotrophic lateral sclerosis
Formulary ; ... Neurology 1993;43:2466-70. 37. The NDA pipeline-1996. 15th ed. Chevy Chase, MD: FDC reports. 38. What's in the pipeline. MedAd News 1997. [Author Affiliation] Dr. White is clinical pharmacist Connecticare, Inc, Farmington, CT Dr Felice is assistant professor ...
Sensory Testing in the Assessment of Laryngeal Sensation in Patients With Amyotrophic Lateral Sclerosis
The Annals of Otology, Rhinology & Laryngology ; Objectives: Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron disease of unknown cause. Mortality in the population is frequently due to aspiration pneumonia. Although typically considered to be a disorder limited to motor neuron involvement, some investigators have indicated that
Assisting People With ALS
The Washington Post ; Amyotrophic lateral sclerosis, or Lou Gehrig's disease, is a degenerative motor neuron disease that progresses from muscle weakness to paralysis. The 5,000 Americans diagnosed with ALS every year face a bleak forecast: Life expectancy after diagnosis is typically two to five years, and for much of
ALS organization names board officers
The Milwaukee Journal Sentinel ; The board of directors of the Southeast Wisconsin Chapter of the Amyotrophic Lateral Sclerosis Association recently elected its new officers and board members. Officers include: Christine Schultz of Menomonee Falls, president; Jeffrey Kaufman of Brookfield, vice president; Jeanine Petit of
Hitachi Electronics Services to Support Japan Amyotrophic Lateral Sclerosis Association (JALSA) with Communication Device Rental Service
JCNN News Summaries - Japan Corporate News Network ; On April 12, Hitachi Electronics Services announced that it will join Hitachi and Hitachi Keiyo Engineering & Systems in lending communication devices for use by patients with amyotrophic lateral sclerosis (ALS). Denno-shin is a device that helps ALS patients suffering from a severe speech defect
Vitamin E decreases risk of death from ALS.(ABSTRACTS OF INTEREST)(amyotrophic lateral sclerosis)(Brief Article)(Author Abstract)
Original Internist ; In a brief communication published in the Annals of Neurology, researchers at Harvard School of Public Health determined that regular users of vitamin E, but not vitamin C, have a decreased risk of dying from amyotrophic lateral sclerosis (ALS) than nonusers. This prospective study monitored the